Latest Breaking News On - Boston vertex pharmaceuticals - Page 1 : vimarsana.com

Gene-editing startup Tome Biosciences buys Replace Therapeutics

The formal launch of Tome and its buyout of Replace Therapeutics come just as regulators in the US and Europe have approved the first gene-editing drug.

Al iskandariyahUnited statesSouth bostonOmar abudayyehAndreessen horwitzFeng zhangJonathan gootenbergBrucker corpBroad instituteBoston vertex pharmaceuticalsLongwood fundVertex pharmaceuticalsApple watchSan franciscoPolaris partnersSilicon valley

Biotechs pursue gene-editing therapies for range of diseases

Drug makers in Mass. and beyond are deploying gene editing, which snips sequences of patients’ DNA, to develop dozens of other treatments for cancers, heart disease, diabetes, and rare genetic disorders.

South bostonUnited statesUnited kingdomNorth carolinaDana farber cancer instituteJennifer doudnaJohn evansDavid liuSamarth kulkarniSekar kathiresanEmmanuelle charpentierEli lillyGilmore oneillStuart orkinKeith gottesdienerGeorge church

Transformative gene therapies could reduce sickle cell disease complications Here s how Massachusetts played a part

Boston's Vertex Pharmaceuticals and Somerville's Bluebird Bio helped create the FDA-approved treatments.

United statesMassachusetts sickle cell associationDrug administrationHospital comprehensive sickle cell disease treatment centerBoston vertex pharmaceuticalsVertex pharmaceuticalsBluebird bioSharl azarGreater boston

Dallas Medical City Children s To Offer New CRISPR Gene Editing Therapy for Sickle Cell Disease

Dallas Medical City Children s To Offer New CRISPR Gene Editing Therapy for Sickle Cell Disease
dallasinnovates.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallasinnovates.com Daily Mail and Mail on Sunday newspapers.

Fort worthUnited statesSan antonioSamarth kulkarniStephan gruppReshma kewalramaniLos angelesKelly centerBoston vertex pharmaceuticalsVertex pharmaceuticalsCity childrenMedical city childrenMethodist childrenCellular therapyTransplant sectionDallas fort worth

The UK becomes the first country to approve CRISPR treatment

The new therapy uses gene editing to treat sickle cell disease and beta thalassemia.

United kingdomUnited statesAlena panceJennifera doudnaEmmanuelle charpentierScience media centreRegulatory agencyDrug administrationBoston vertex pharmaceuticalsUniversity of hertfordshireMiddle easternVertex pharmaceuticalsCrispr therapeuticsScience mediaUnited states foodSickle cell disease